Authors

  • Jamolova Maftuna Istamovna
  • Sadullaeva Sitora Jamolovna

Author Biographies

  • Jamolova Maftuna Istamovna

    Afshona is a vocational science teacher at the technical school of public health named after Abu Ali Ibn Sina

  • Sadullaeva Sitora Jamolovna

    Afshona is a vocational science teacher at the technical school of public health named after Abu Ali Ibn Sina

DOI:

https://doi.org/10.71337/inlibrary.uz.mead.117280

Keywords:

Ischemic Heart Disease (IHD) Coronary Artery Disease (CAD) Stable Angina Unstable Angina Myocardial Infarction (MI) Percutaneous Coronary Intervention (PCI) Coronary Artery Bypass Grafting (CABG) Antiplatelet Therapy Statins Lifestyle Modifications.

Abstract

Ischemic heart disease (IHD), primarily resulting from coronary artery disease (CAD), remains a leading cause of morbidity and mortality worldwide. This article provides an in-depth analysis of the classification of IHD, including stable and unstable angina, and myocardial infarction (MI). It also discusses contemporary treatment strategies encompassing lifestyle modifications, pharmacological interventions, and revascularization procedures.


background image

MODERN EDUCATION AND DEVELOPMENT

Выпуск журнала №-26

Часть–5_ Май –2025

123

CLASSIFICATION AND TREATMENT OF ISCHEMIC HEART

DISEASE: A COMPREHENSIVE OVERVIEW

Jamolova Maftuna Istamovna

Afshona is a vocational science teacher at the technical school of public

health named after Abu Ali Ibn Sina

Sadullaeva Sitora Jamolovna

Afshona is a vocational science teacher at the technical school of public

health named after Abu Ali Ibn Sina

Abstract: Ischemic heart disease (IHD), primarily resulting from coronary

artery disease (CAD), remains a leading cause of morbidity and mortality worldwide.

This article provides an in-depth analysis of the classification of IHD, including stable

and unstable angina, and myocardial infarction (MI). It also discusses contemporary

treatment strategies encompassing lifestyle modifications, pharmacological

interventions, and revascularization procedures.

Keywords: Ischemic Heart Disease (IHD), Coronary Artery Disease (CAD),

Stable Angina, Unstable Angina, Myocardial Infarction (MI), Percutaneous Coronary

Intervention (PCI), Coronary Artery Bypass Grafting (CABG), Antiplatelet Therapy,

Statins, Lifestyle Modifications.

1. Introduction

Ischemic heart disease occurs when the coronary arteries are narrowed or

blocked, leading to reduced blood flow to the heart muscle. This condition manifests

in various forms, including stable angina, unstable angina, and myocardial infarction,

each requiring distinct management approaches.

2. Classification of Ischemic Heart Disease

2.1 Stable Angina


background image

MODERN EDUCATION AND DEVELOPMENT

Выпуск журнала №-26

Часть–5_ Май –2025

124

Stable angina is characterized by predictable chest pain or discomfort triggered

by physical exertion or stress, relieved by rest or nitroglycerin. It results from fixed

atherosclerotic plaques causing partial obstruction of coronary arteries.

2.2 Unstable Angina

Unstable angina presents with chest pain that is more frequent, intense, or

occurs at rest, indicating a rupture of an atherosclerotic plaque and formation of a

thrombus. It is a medical emergency and a precursor to myocardial infarction.

2.3 Myocardial Infarction

Myocardial infarction occurs when a coronary artery is completely occluded,

leading to irreversible damage to the heart muscle. It is classified into two types:

ST-Elevation Myocardial Infarction (STEMI):

Characterized by a

significant elevation in the ST segment on an electrocardiogram, indicating a full-

thickness myocardial injury.

Non-ST-Elevation Myocardial Infarction (NSTEMI):

Characterized

by elevated cardiac biomarkers without significant ST-segment elevation, indicating

partial-thickness myocardial injury.

3. Treatment Strategies

3.1 Lifestyle Modifications

Lifestyle changes are fundamental in managing IHD and include:(

American

College of Cardiology

)

Smoking Cessation:

Reduces the risk of atherosclerosis progression.

Dietary Modifications:

Adopting a heart-healthy diet rich in fruits,

vegetables, and whole grains.(

CardioSmart

)

Regular Physical Activity:

Engaging in moderate exercise to improve

cardiovascular health.

Weight Management:

Achieving and maintaining a healthy weight to

reduce cardiac workload.

Stress Management:

Implementing techniques to manage stress and

reduce its impact on heart health.

3.2 Pharmacological Interventions


background image

MODERN EDUCATION AND DEVELOPMENT

Выпуск журнала №-26

Часть–5_ Май –2025

125

Pharmacotherapy aims to alleviate symptoms, prevent disease progression, and

reduce the risk of adverse cardiovascular events:

Antiplatelet Agents:

Aspirin and clopidogrel inhibit platelet aggregation,

reducing the risk of thrombotic events. (

ahajournals.org

)

Statins:

Lower low-density lipoprotein (LDL) cholesterol levels,

stabilizing atherosclerotic plaques. (

Angolo del Dottorino

)

Beta-Blockers:

Reduce heart rate and myocardial oxygen demand,

alleviating angina symptoms. (

Angolo del Dottorino

)

Angiotensin-Converting

Enzyme

(ACE)

Inhibitors:

Improve

endothelial function and reduce blood pressure. (

Angolo del Dottorino

)

Calcium Channel Blockers:

Relieve coronary vasospasm and reduce

myocardial oxygen demand. (

Angolo del Dottorino

)

3.3 Revascularization Procedures

Revascularization is considered in patients with significant coronary artery

obstruction:

Percutaneous Coronary Intervention (PCI):

Involves angioplasty and

stent placement to restore blood flow.

Coronary Artery Bypass Grafting (CABG):

Surgical procedure to

bypass blocked coronary arteries using grafts.

4. Conclusion

Effective management of ischemic heart disease requires a comprehensive

approach encompassing lifestyle modifications, pharmacological therapy, and, when

necessary, revascularization procedures. Early diagnosis and individualized treatment

plans are crucial in improving patient outcomes and quality of life.

REFERENCES

1.

American College of Cardiology. (2014). ACCEL: The Guidelines for

Managing Patients with Stable Ischemic Heart Disease. Retrieved from

https://www.acc.org/Latest-in-Cardiology/Articles/2014/02/12/14/27/ACCEL-The-

Guidelines-for-Managing-Patients-with-Stable-Ischemic-Heart-Disease

(

American

College of Cardiology

)


background image

MODERN EDUCATION AND DEVELOPMENT

Выпуск журнала №-26

Часть–5_ Май –2025

126

2.

American College of Cardiology. (2014). Guideline for Treating Stable Ischemic

Heart

Disease.

CardioSmart.

Retrieved

from

https://www.cardiosmart.org/news/2014/7/guideline-for-treating-stable-ischemic-

heart-disease

(

CardioSmart

)

3.

American

Heart

Association.

(2012).

2012

ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and

Management of Patients With Stable Ischemic Heart Disease. Circulation, 126(25),

e354-e471. doi:10.1161/CIR.0b013e318277d6a0(

ahajournals.org

)

4.

StatPearls Publishing. (2020). Chronic Ischemic Heart Disease Selection of

Treatment

Modality.

StatPearls.

Retrieved

from

https://www.ncbi.nlm.nih.gov/sites/books/N